T. Rowe Price US Blue Chip Eq I EUR 2

Performance History30/04/2024
Growth of 1,000 (EUR)
T. Rowe Price US Blue Chip Eq I EUR 2
Fund----14.0
+/-Cat----4.3
+/-Idx----3.6
 
Key Stats
NAV
02/05/2024
 EUR 12.90
Day Change -1.07%
Morningstar Category™ US Large-Cap Growth Equity
ISIN LU2616614389
Fund Size (Mil)
02/05/2024
 USD 717.79
Share Class Size (Mil)
02/05/2024
 EUR 0.01
Max Initial Charge -
Ongoing Charge
01/02/2024
  0.64%
Investment Objective: T. Rowe Price US Blue Chip Eq I EUR 2
To increase the value of its shares, over the long term, through growth in the value of its investments.
Returns
Trailing Returns (EUR)02/05/2024
YTD12.76
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield -
Management
Manager Name
Start Date
Paul Greene
01/10/2021
Inception Date
01/06/2023
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
S&P 500 (Net of 30% withhg tax)Morningstar US LM Brd Growth NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  T. Rowe Price US Blue Chip Eq I EUR 231/03/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks99.200.0099.20
Bonds0.240.000.24
Cash0.560.000.56
Other0.000.000.00
Top 5 Regions%
United States96.07
Eurozone1.82
Europe - ex Euro1.19
Asia - Developed0.70
United Kingdom0.23
Top 5 Sectors%
Technology41.51
Consumer Cyclical16.25
Healthcare13.64
Communication Services12.81
Financial Services10.15
Top 5 HoldingsSector%
Microsoft CorpTechnologyTechnology9.73
Amazon.com IncConsumer CyclicalConsumer Cyclical9.66
NVIDIA CorpTechnologyTechnology9.33
Apple IncTechnologyTechnology8.82
Alphabet Inc Class CCommunication ServicesCommunication Services4.75
T. Rowe Price US Blue Chip Eq I EUR 2

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures